Literature DB >> 21099307

B cell therapy is β-tested: Rituximab puts a pause on β-cell destruction.

Raphael Clynes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099307     DOI: 10.4161/isl.2.2.11452

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


× No keyword cloud information.
  3 in total

Review 1.  The pathogenesis and natural history of type 1 diabetes.

Authors:  Mark A Atkinson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 2.  Adaptive immunity in obesity and insulin resistance.

Authors:  Henrike Sell; Christiane Habich; Juergen Eckel
Journal:  Nat Rev Endocrinol       Date:  2012-07-31       Impact factor: 43.330

3.  Regulation of type 2 diabetes by helminth-induced Th2 immune response.

Authors:  Motoko Morimoto; Noritsugu Azuma; Hikaru Kadowaki; Tatsuya Abe; Yoshiko Suto
Journal:  J Vet Med Sci       Date:  2016-09-22       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.